Literature DB >> 10942461

Initial development of a system-wide maternal-fetal outcomes assessment program.

W M Novicoff1, D P Wagner, W A Knaus, E K Kane, F Cecere, E Draper, J E Ferguson.   

Abstract

OBJECTIVE: This study was undertaken to develop a comprehensive risk-assessment approach capable of evaluating maternal and fetal outcomes. STUDY
DESIGN: Data from 10,984 women and 11,066 infants delivered at 79 military treatment facilities in the United States from 1995 to 1997 were used to develop two individual but complementary risk-adjustment models for maternal and, separately, fetal outcomes. A range of maternal and delivery-related risk variables and clinically important outcomes were identified by expert opinion and selected and weighted with ordinal logistic regression analysis. Receiver operating characteristic curves for the maternal and fetal models were determined. Variation across the facilities in risk-adjusted performance was also evaluated.
RESULTS: Risk factors and poor outcomes were rare for both mothers and infants, with 96.9% of infants and 97.7% of mothers having good or excellent outcomes (0.7% mortality and 0.01% mortality, respectively). Despite the low frequency of poor outcomes both models performed well, with receiver operating characteristic curves of 0.75 for maternal outcomes and 0.78 for infant outcomes. When the models were applied to the military treatment facilities, there were significant differences among facilities in risk-adjusted outcomes. Twenty-four of the facilities in the study (30%) had outcomes odds ratios that were significantly >1 or significantly <1 (P <.05). There did not appear to be any relationship between the performance of a military treatment facility for maternal outcome and that for infant outcome.
CONCLUSION: Complementary risk models for maternal and infant outcomes were developed that had satisfactory discriminatory power across a variety of facilities within a large health system. With further development and refinement this approach holds promise of being able to detect variations in risk-adjusted performance that could be used to identify best practices. The results might also be used to help coordinate and improve the quality of care for the entire conception-to-delivery process.

Entities:  

Mesh:

Year:  2000        PMID: 10942461     DOI: 10.1067/mob.2000.108087

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Does delivery volume of family physicians predict maternal and newborn outcome?

Authors:  Michael C Klein; Andrea Spence; Janusz Kaczorowski; Ann Kelly; Stefan Grzybowski
Journal:  CMAJ       Date:  2002-05-14       Impact factor: 8.262

2.  Incidence of severe adverse neonatal outcomes: use of a composite indicator in a population cohort.

Authors:  Samantha J Lain; Charles S Algert; Natasha Nassar; Jennifer R Bowen; Christine L Roberts
Journal:  Matern Child Health J       Date:  2012-04

3.  A systematic approach for establishing the range of recommended weight gain in pregnancy.

Authors:  Jennifer A Hutcheon; Lisa M Bodnar
Journal:  Am J Clin Nutr       Date:  2014-06-25       Impact factor: 7.045

4.  Using perinatal morbidity scoring tools as a primary study outcome.

Authors:  Jennifer A Hutcheon; Lisa M Bodnar; Robert W Platt
Journal:  J Epidemiol Community Health       Date:  2017-11       Impact factor: 3.710

5.  Rating the seriousness of maternal and child health outcomes linked with pregnancy weight gain.

Authors:  Lisa M Bodnar; Dmitry Khodyakov; Sara M Parisi; Katherine P Himes; Jessica G Burke; Jennifer A Hutcheon
Journal:  Paediatr Perinat Epidemiol       Date:  2020-11-20       Impact factor: 3.103

6.  Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model.

Authors:  Beth A Payne; Helen Ryan; Jeffrey Bone; Laura A Magee; Alice B Aarvold; J Mark Ansermino; Zulfiqar A Bhutta; Mary Bowen; J Guilherme Cecatti; Cynthia Chazotte; Tim Crozier; Anne-Cornélie J M de Pont; Oktay Demirkiran; Tao Duan; Marlot Kallen; Wessel Ganzevoort; Michael Geary; Dena Goffman; Jennifer A Hutcheon; K S Joseph; Stephen E Lapinsky; Isam Lataifeh; Jing Li; Sarka Liskonova; Emily M Hamel; Fionnuala M McAuliffe; Colm O'Herlihy; Ben W J Mol; P Gareth R Seaward; Ramzy Tadros; Turkan Togal; Rahat Qureshi; U Vivian Ukah; Daniela Vasquez; Euan Wallace; Paul Yong; Vivian Zhou; Keith R Walley; Peter von Dadelszen
Journal:  Crit Care       Date:  2018-10-30       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.